By InvitationNot Applicable

Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome

Mexico94 participantsStarted 2024-03-14

Plain-language summary

Irritable bowel syndrome is characterized by the presence of chronic, recurrent abdominal pain, alterations in bowel habits, and abdominal distension. The medical diagnosis is made using the Rome IV criteria. There are three IBS phenotypes: diarrhea-predominant, constipation-predominant, and mixed.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Must be over 18 years old. * Be an employee or beneficiary of UANL. * Have gastrointestinal alterations (diarrhea, constipation, etc.) that suggest the presence of irritable bowel syndrome. * Not be under any medical treatment. Exclusion Criteria: * Being under medical treatment. * Not having gastrointestinal alterations much as diarrhea, constipation, etc. * being under 18 years old. * Not being an employee or beneficiary of UANL.

What they're measuring

Effect of the Consumption of a Nutraceutical Composition on Signs and Symptoms in Adult Patients with Irritable Bowel Syndrome.

Timeframe: 1 year

Trial details

NCT IDNCT07103772

SponsorUniversidad Autonoma de Nuevo Leon

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-14

View on ClinicalTrials.gov More Irritable Bowel Syndrome trials